Clinical trial
Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With…
NCT00120172 · Geriatric Oncology Consortium, Other · Terminated
Key facts
| NCT number | NCT00120172 |
|---|---|
| Title | Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer |
| Official title | A Phase II Study of Oxaliplatin, Capecitabine, and Bevacizumab in the Treatment of Elderly Patients With Metastatic Colorectal Cancer |
| Lead sponsor | Geriatric Oncology Consortium, Other |
| Collaborators | Sanofi Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Neoplasm Metastasis |
| Intervention type | Drug |
| Interventions | oxaliplatin, capecitabine, bevacizumab |
| Enrollment | 40 |
| Start date | May 1, 2005 |
| Completion | Jun 1, 2006 |
| First posted | Jul 15, 2005 |
| Last update posted | Nov 16, 2007 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: